PLIANT THERAPEUTICS, INC.
Recent Filings
All 405 filings →| Form | Description | Date |
|---|---|---|
| S-8 | S-8 | Mar 11, 2026 |
| 8-K | 8-K | Mar 11, 2026 |
| 10-K | 10-K | Mar 11, 2026 |
| 8-K | 8-K | Mar 3, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G | — | Feb 9, 2026 |
| SCHEDULE 13G | — | Jan 30, 2026 |
| 4 | FORM 4 | Jan 26, 2026 |
| 4 | FORM 4 | Jan 26, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Cheung Lily | Chief Human Resource Officer | Award / Grant | 25,875 | 50,425 | Jan 23, 2025 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Award / Grant | 35,000 | 105,544 | Jan 23, 2025 |
| Hull Hans | Chief Business Officer | Award / Grant | 40,150 | 251,708 | Jan 23, 2025 |
| Lefebvre Eric | Chief Medical Officer | Award / Grant | 45,650 | 240,224 | Jan 23, 2025 |
| Cummings Keith Lamont | Chief Financial Officer | Award / Grant | 56,650 | 319,258 | Jan 23, 2025 |
| Coulie Bernard | President and CEO | Award / Grant | 162,500 | 593,017 | Jan 23, 2025 |
| Coulie Bernard | President and CEO | Sale | 52,419 @ $11.20 | 430,517 | Jan 17, 2025 |
| Cummings Keith Lamont | Chief Financial Officer | Sale | 20,148 @ $11.20 | 262,608 | Jan 17, 2025 |
| Hull Hans | Chief Business Officer | Sale | 15,936 @ $11.20 | 211,558 | Jan 17, 2025 |
| Lefebvre Eric | Chief Medical Officer | Sale | 18,478 @ $11.20 | 194,574 | Jan 17, 2025 |